NEW YORK (GenomeWeb News) – Women's health diagnostics company Inex Innovations Exchange announced today a partnership with BGI to create a next-generation sequencing facility in Singapore to offer molecular genetic tests.

The first test to be offered will be iGeneScreen, a non-invasive test developed by BGI to detect fetal chromosomal abnormalities. Using a 5 milliliter blood sample from expectant mothers at 12 weeks or later into their pregnancies, the test analyzes fetal DNA in maternal blood for trisomies 21, 18, and 13.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.